60 related articles for article (PubMed ID: 3671446)
21. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
22. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
23. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
Park YH; Jung BH; Chung BC; Park J; Mitoma C
Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
[TBL] [Abstract][Full Text] [Related]
24. Absorption, distribution and excretion of [14C]-Lesopitron after single and repeated administration in rats and dogs.
Serafini MT; Puig S; García-Encina G; Farran R; García-Soret A; Moragon T; Martínez L
Methods Find Exp Clin Pharmacol; 1997; 19(1):61-72. PubMed ID: 9098842
[TBL] [Abstract][Full Text] [Related]
25. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
Ando T; Momota K; Sugiyama M
Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
[TBL] [Abstract][Full Text] [Related]
26. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and disposition of diphacinone in rats and mice.
Yu CC; Atallah YH; Whitacre DM
Drug Metab Dispos; 1982; 10(6):645-8. PubMed ID: 6130915
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma.
Steinke W; Ahr HJ; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280
[TBL] [Abstract][Full Text] [Related]
29. Toxicokinetics of 14C-endosulfan in male Sprague-Dawley rats following oral administration of single or repeated doses.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Sugimoto M; Yoneda M
Environ Toxicol; 2005 Oct; 20(5):533-41. PubMed ID: 16161119
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and disposition of L-692,429. A novel nonpeptidyl growth hormone secretagogue in preclinical species.
Leung KH; Cohn DA; Miller RR; Doss GA; Stearns RA; Simpson RE; Feeney WP; Chiu SH
Drug Metab Dispos; 1996 Jul; 24(7):753-60. PubMed ID: 8818572
[TBL] [Abstract][Full Text] [Related]
31. The use of combustion technique of tissue processing for the study of the distribution of 14C-salicylate in rats after oral administration.
Saran-Kumar KV
Indian J Physiol Pharmacol; 1981; 25(3):285-8. PubMed ID: 7298155
[TBL] [Abstract][Full Text] [Related]
32. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.
Cossum PA; Sasmor H; Dellinger D; Truong L; Cummins L; Owens SR; Markham PM; Shea JP; Crooke S
J Pharmacol Exp Ther; 1993 Dec; 267(3):1181-90. PubMed ID: 8166890
[TBL] [Abstract][Full Text] [Related]
33. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
[TBL] [Abstract][Full Text] [Related]
34. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
35. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
[TBL] [Abstract][Full Text] [Related]
36. Metabolic disposition of the acyclovir prodrug valaciclovir in the rat.
Burnette TC; de Miranda P
Drug Metab Dispos; 1994; 22(1):60-4. PubMed ID: 8149891
[TBL] [Abstract][Full Text] [Related]
37. Absorption and disposition of [14C]-molsidomine in laboratory animals.
Fromson JM; Illing HP; Ings RM; Johnson KI; Johnson P; Ostrowski J; Schraven E; Steward A
Arzneimittelforschung; 1981; 31(2):337-45. PubMed ID: 6894378
[TBL] [Abstract][Full Text] [Related]
38. Disposition and metabolism of [14C]-haloperidol in rats.
Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
[TBL] [Abstract][Full Text] [Related]
39. [Distribution of 4-14C-mofebutazone in the rat].
Loew D; Schuster O; Graul EH
Z Rheumatol; 1986; 45(2):83-6. PubMed ID: 3727816
[TBL] [Abstract][Full Text] [Related]
40. Urinary metabolites of centperazine.
Agarwal N; Srivastava VM; Bhatt GR; Sircar KP; Sharma S
Indian J Exp Biol; 1987 Jun; 25(6):400-4. PubMed ID: 3440577
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
